Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve

Nicholas Fidelman;Curt Johanson;Maureen P Kohi;K Pallav Kolli;Ryan M Kohlbrenner;Evan D Lehrman;Andrew G Taylor;R Kate Kelley;Francis Y Yao;John P Roberts;Robert K Kerlan;
journal of hepatocellular carcinoma 2019 Vol. 6 pp. 93--103
238
fidelman2019prospectivejournal

Abstract

Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve

Access

DOI:
10.2147/JHC.S206979
URL:
https://www.dovepress.com/getfile.php?file

Citation

ID: 10744
Ref Key: fidelman2019prospectivejournal
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
10744
Unique Identifier:
10.2147/JHC.S206979
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store